30 filings · most recent first
TERN 8-K Filings
Merck Completes Acquisition Of Terns Pharmaceuticals
Fda Grants Breakthrough Therapy Designation To Terns Pharmaceuticals Tern701
Merck To Acquire Terns Pharmaceuticals For 5300 Per Share In Cash
Terns Pharmaceuticals Amends Exclusive License Agreement With Hansoh
Terns Pharmaceuticals Announces 2026 Priorities And Financial Update
Terns Pharmaceuticals Announces Pricing Of 650 Million Public Offering
Terns Pharmaceuticals Announces Positive Phase 1 Data For Tern701 At Ash 2025
Terns Pharmaceuticals Reports Q3 2025 Financial Results And Clinical Updates
Terns Pharmaceuticals Announces Positive Tern701 Data At Ash Annual Meeting
Terns Pharmaceuticals Halts Development Of Tern601 For Obesity
Terns Pharmaceuticals Announces Pricing Of Public Offering
Terns Pharmaceuticals Appoints New Ceo Amy Burroughs
Terns Pharmaceuticals Reports Second Quarter 2025 Financial Results And
Terns Pharmaceuticals Announces 2025 Annual Meeting Voting Results
Terns Pharmaceuticals Reports Q1 2025 Results And Clinical Updates
Terns Pharmaceuticals Reports 2024 Financial Results And Key Developments
Terns Pharmaceuticals Appoints New Cfo
Terns Pharmaceuticals Appoints New Director And Announces Resignation Of
Terns Pharmaceuticals Announces Cfo Resignation
Terns Pharmaceuticals Announces Positive Early Data From Phase 1 Cardinal Trial
Terns Pharmaceuticals Announces Board Changes
Terns Pharmaceuticals Reports Q3 2024 Financial Results And Corporate Updates
Terns Pharmaceuticals Announces Positive Phase 1 Results For Tern601 In Obesity
Terns Pharmaceuticals Reports Q2 2024 Financial Results And Corporate Updates
Terns Pharmaceuticals Announces Key Executive Transitions And New Leadership
Terns Pharmaceuticals Extends Office Lease Agreement
Terns Pharmaceuticals Inc Announces Stockholder Voting Results For 2024 Annual
Terns Pharmaceuticals Reports Q1 2024 Financial Results And Pipeline Updates
Terns Pharmaceuticals Announces Positive Phase 1 Data For Tern701
Terns Pharmaceuticals Announces Fourth Quarter And Full Year 2023 Financial